1. European Urology Oncology
Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists 
Simon P. Kim, Nilay D. Shah, Neal J. Meropol, Jon C. Tilburt, Paul L. Nguyen, James B. Yu, Robert Abouassaly, Albert Kim, Cary P. Gross 
European Urology Oncology 
DOI: /j.euo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1
(A) Respondents’ perceptions of the effectiveness of and comfort with routinely recommending active surveillance (AS) for intermediate-risk prostate cancer by specialty (p<0.001 for comfortable recommending AS). (B) Self-reported proportion of patients undergoing active surveillance among patients diagnosed with intermediate-risk prostate cancer (all p<0.001). RO=radiation oncologist; URO=urologist.
European Urology Oncology DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions